Delivery Order SPE2DB20D3103-SPE2DB24FL9U7

Award Date 12/19/23
Potential Completion Date 12/20/23
Potential Value $1.5K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4,563,943,955 units of 25 mg hydrocortisone suppositories. The award, valued at $1,453.38, was made by the Defense Logistics Agency (DLA) on March 12, 2024 and has a period of performance through March 13, 2024. The contract is a firm fixed price delivery order and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,798.06 firm fixed-price delivery order is for the supply of 4,566,620,549 units of 25 mg hydrocortisone acetate suppositories. The contract has an ultimate completion date of December 6, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, valued at $2,626.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 14, 2023. The award is for the delivery of 4,562,179,260 units of hydrocortisone acetate 30 mg suppositories, with a completion date of September 15, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This federal contract award, with ID SPE2DX15D3112|SPE2DX24FDZGT, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,979.73 firm fixed-price delivery order is for the supply of 4562986960 - Hydrocortisone AC 25 mg Suppositories in quantities of 12. The contract has a completion date of December 5, 2023 and was awarded on December 4, 2023. This award is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,567,038,369 units of 5 mg Hydrocortisone tablets. The firm-fixed-price, $5,525.52 delivery order contract runs through January 27, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,584.80, is for the supply of 4567675431 ! HYDROCORTISONE AC 25 MG SUPP 24S. The contract has an ultimate completion date of March 25, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 453.6 grams of hydrocortisone with a potential value of $2,608.89 and a performance period through February 12, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) valued up to $999,999,999.00 with DLA, which serves as the primary...
The Defense Logistics Agency awarded a $155,100 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561654536 Hydrocortisone Acetate 25mg Suppositories in quantities of 12 each. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from July 31, 2023 through August 1, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,628.84, is for the delivery of 4567571357 - HYDROCORTISONE AC 25 MG SUPP 12S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 14, 2025. There is no set-aside designation for this...
This is a delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,326.76 firm fixed-price contract is for the supply of 4566934854 - Hydrocortisone AC 25 MG SUPP 24S, with a completion date of January 16, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FL9U7
    Delivery Order

The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,563,142,252 units of 25mg Hydrocortisone Acetate Suppositories. The firm-fixed-price contract has a ceiling value of $1,523.56 and an ultimate completion date of December 20, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which covers a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract did not have a set-aside designation, indicating open competition.

Generated 5/13/25, 10:30 AM